AngioDynamics Inc (ANGO) stock

ANGONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends May 31

Financials through Q1 FY2027, quarter ended Aug 31, 2026Last filing: 10-Q on Oct 8, 2026Score 12/309% below fair value

$11.98−0.44 (-3.50%)

Close on Nov 12, 2026Market cap $504.02MP/E –Yield –

AngioDynamics EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

AngioDynamics's EV/EBITDA was 8.4× on Mar 28, 2024, against 18.0× a year earlier. Over the last 5 years it ranged from 7.1× to 979.5×, with a median of 20.1×.

EV/EBITDA at the end of each year

Period	Period end	Value	Change (pts)
2024	Mar 28, 2024	8.4×	−1.1
2023	Dec 29, 2023	9.5×	−870.4
2022	Sep 30, 2022	880.0×	+858.4
2020	Jun 30, 2020	21.5×	−3.0
2019	Dec 31, 2019	24.5×	−297.1
2018	Dec 31, 2018	321.6×	+254.4
2017	Dec 29, 2017	67.2×	+48.2
2016	Dec 30, 2016	19.0×	+1.8
2015	Dec 31, 2015	17.2×	+1.7
2014	Dec 31, 2014	15.5×	−6.2
2013	Dec 31, 2013	21.8×	−24.2
2012	Dec 31, 2012	46.0×	+35.8
2011	Dec 30, 2011	10.2×	+0.5
2010	Dec 31, 2010	9.7×	–

Where these numbers come from

Parsed from the XBRL in AngioDynamics's annual and quarterly filings with the SEC
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing